Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-21-071314

Senior Vice President, Finance sold 295 shares at $33.10 ($9,765)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Senior Vice President, Finance 2021-12-27 Sale −295 $33.10 $9,765 14,989 D: show line 1 in the form
Open-market sales · 295 sh · avg $33.10 · $9,765
Loading xslF345X03/doc4.xml…